Across TCGA pan-cancer cohorts, UBE2QL1 Mutation is linked to patient survival in 1 of 34 cancer types, making it a survival-associated UBE2QL1 data layer compared with 23 for mass-spec protein.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher UBE2QL1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated UBE2QL1 expression acts as an unfavorable survival marker.

ESCA are the cancer types where UBE2QL1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Median	All	0.198	0.872	.003	18	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: UBE2QL1 tumor-vs-normal RNA expression · all UBE2QL1 data types